Breast Cancer Clinical Trial

The Effect of Acupuncture on Cancer-Related Cognitive Difficulties

Summary

The purpose of this study is to test whether acupuncture can improve cognitive difficulties and insomnia in survivors of breast cancer. Researchers will compare the effects of real acupuncture with those of placebo acupuncture and wait-list acupuncture. This study will also look at insomnia's link to cognitive difficulties.

All study participants (receiving real acupuncture, placebo acupuncture, or wait-list acupuncture) will complete study questionnaires and/or have cognitive testing at Weeks 0, 4, 10, 14 and 26. After the Week 26 visit, your participation in this study will end. If you are assigned to receive placebo acupuncture or wait-list acupuncture, you will have the option of receiving up to 10 real acupuncture treatments within the six months after the study finishes.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

English-proficient adult women with a history of stage 0, I, II, or III breast cancer
Free of oncologic disease by clinical examination or history
Moderate or greater CRCD as indicated by a score of "quite a bit" or "very much" on at least one of the two items that specifically assess concentration and memory on the EORTC QLQ-C30 (version 3.0)

Report that cognitive functions worsened since cancer diagnosis by replying "Yes" to all 3 questions

Do you think or feel that your memory or mental ability has gotten worse since your cancer diagnosis?
Do you think your mind isn't as sharp now as it was before your cancer diagnosis?
Do you feel like these problems have made it harder to function on your job or take care of things around the home?
Presence of insomnia symptoms as indicated by a score ≥8 on the ISI134
Willing to adhere to all study-related procedures, including randomization to one of the 3 possible choices: acupuncture, sham acupuncture, or wait-list control

Exclusion Criteria:

Metastatic breast cancer (stage IV)
Less than 1 month since completion of surgery, chemotherapy or radiation therapy
Greater than 10 years since most recent breast cancer diagnosis
Use of acupuncture for sleep or cognitive symptom management within the past 3 months
Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder
Score of >10 indicative of overt dementia on the Blessed Orientation-Memory-Concentration (BOMC)135
Primary psychiatric disorder not in remission
As per medical record or self-report, history of stroke or head injury requiring visit to the emergency room or hospitalization, with confirmed structural lesion on neuroimaging, persistent cognitive difficulties impacting work or daily life, or required cognitive rehabilitation.
Pre-existing, uncorrectable visual or auditory impairment that would preclude ability to complete the assessments
Initiation or change in hormonal or targeted therapy within the past 4 weeks
Plans to initiate or change hormonal or targeted therapy in the coming 8 weeks
Altered dose of somnogenic medication (e.g. hypnotics, sedatives, antidepressants) in past 8 weeks
Enrolled or plans to enroll on another MSK neurocognitive study
Unable to provide informed consent for himself/herself

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

260

Study ID:

NCT04837820

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)
Commack New York, 11725, United States More Info
Jun Mao, MD, MSCE
Contact
646-888-0866
Memoral Sloan Kettering Westchester (Limited Protocol Activities)
Harrison New York, 10604, United States More Info
Jun Mao, MD, MSCE
Contact
646-888-0863
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Jun Mao, MD, MSCE
Contact
646-888-0866
Kevin Liou, MD
Contact
646-888-0864
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale New York, 11553, United States More Info
Jun Mao, MD, MSCE
Contact
646-888-0866

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

260

Study ID:

NCT04837820

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.